Transgene inks licensing pact with Portugal's Atral Cipan
Hindu Business Line
Biotechnology company Transgene Biotek today said it has entered into a licensing and technology transfer agreement with Portugal-based Atral Cipan for its immunosuppressive drug Tacrolimus. As a result of this agreement, Atral Cipan will move the ...
Transgene Biotek inks pact with Atral CipanBusiness Standard
Transgene Signs Licensing And Technology Transfer Pact With Atral CipanRTT News

all 4 news articles »